OraPharma Report issue

For profit Phase 2 Phase 4
Founded: Bridgewater NJ United States (1996)
Status: Acquired by Johnson and Johnson (2002)

Organization Overview

First Clinical Trial
2004
NCT00371332
First Marketed Drug
2001
minocycline (minocin)
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ora Bio Ltd. | Orapharma | ORAPHARMA

Active Ingredients

Marketed Drugs (1)

minocycline (minocin) (2001)

Drugs in Phase 4 Trials (1)

minocycline (minocin) (5 trials)

Drugs in Phase 2 Trials (2)

bevacizumab (avastin) (1 trial)

disulfiram (antabuse) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 4)

Macular Degeneration (Phase 2)

Peri-Implantitis (Phase 3)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 3